Ranokhon Igamberdieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ranokhon Igamberdieva has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Olimkhon Sharapov
Department of Adult and Pediatric Nephrology, Republican Specialized Scientific Practical Medical Center of Nephrology and Kidney Transplantation, Tashkent, Uzbekistan
2 shared publications - Sherzod Abdullaev
Republican Specialized Scientific and Practical Medical Center for Nephrology and Kidney Transplantation, Tashkent State Medical University, Tashkent, Uzbekistan
2 shared publications - Batir Daminov
Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
1 shared publication
Latest Publications
- Open Access
- 2 April 2021
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 10 (3) , e17
Epidemiological, clinical and morphological aspects of kidney damage in COVID-19
The mini-review presents modern data on the epidemiology, clinical and morphological aspects of kidney damage in COVID-19. Potential mechanisms of kidney involvement in the clinical picture of the disease may include cytokine damage, cross-organ damage, and systemic effects that determine the treatment strategy. These mechanisms are closely interrelated and are especially important for individuals undergoing extracorporeal therapy and kidney transplants. Autopsy data provide evidence of SARS-CoV-2 virus invasion into kidney tissue with damage to tubular epithelial cells and podocytes, and erythrocyte aggregation in persons with severe COVID-19. By including people with chronic kidney disease in planned COVID-19 research protocols, an evidence base for effective and safe treatments can be generated.
- 2 April 2021
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 10 (3) , e17
Open AccessEpidemiological, clinical and morphological aspects of kidney damage in COVID-19
The mini-review presents modern data on the epidemiology, clinical and morphological aspects of kidney damage in COVID-19. Potential mechanisms of kidney involvement in the clinical picture of the disease may include cytokine damage, cross-organ damage, and systemic effects that determine the treatment strategy. These mechanisms are closely interrelated and are especially important for individuals undergoing extracorporeal therapy and kidney transplants. Autopsy data provide evidence of SARS-CoV-2 virus invasion into kidney tissue with damage to tubular epithelial cells and podocytes, and erythrocyte aggregation in persons with severe COVID-19. By including people with chronic kidney disease in planned COVID-19 research protocols, an evidence base for effective and safe treatments can be generated.
- Open Access
- 1 April 2021
- Published by Elsevier in Kidney International Reports
- Vol. 6 (4) , S156
POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION
- 1 April 2021
- Published by Elsevier in Kidney International Reports
- Vol. 6 (4) , S156
Open AccessPOS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION